$INSM

$115.50▲ +18.9% YTD

13 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

CP $115.50▲ +18.9%Oct 29, 2026 · ThinkSabio Blog

$INSM Q3 2026: Revenue $524.4m, up 268% YoY BRINSUPRI $400.1m, up 29% QoQ ARIKAYCE $124.4m, up 9% YoY Raised FY26 guidance: BRINSUPRI $1.35b-$1.4b ARI…

News

INSM ▲ +17.4% - Insmed Incorporated

CP $113.95▲ +17.4%Oct 29, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Reports Third-Quarter 2026 Financial Results and Provides Business Update…

News

INSM ▼ -0.0% - Insmed Incorporated

CP $96.27▲ -0.0%Oct 19, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan…

News

INSM ▼ -1.8% - Insmed Incorporated

CP $96.10▲ -1.8%Oct 15, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Features the Global Phase 3 PALM Clinical Development Program Evaluating Treprostinil Palmitil Inhalation Powder (TPIP) at CHEST 2…

News

INSM ▼ -0.1% - Insmed Incorporated

CP $96.71▲ -0.1%Oct 14, 2026 · ThinkSabio Blog

$INSM INSM - Insmed to Present New Data Across Its Respiratory Portfolio at CHEST 2026 and IDWeek 2026…

News

INSM ▼ -4.6% - Insmed Incorporated

CP $106.18▲ -4.6%Oct 5, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Announces CFO Transition…

News

INSM ▼ -4.6% - Insmed Incorporated

CP $106.18▲ -4.6%Oct 5, 2026 · ThinkSabio Blog

$INSM Insmed Announces CFO Transition…

News

INSM ▲ +4.5% - Insmed Incorporated

CP $125.42▲ +4.5%Sep 21, 2026 · ThinkSabio Blog

$INSM INSM - FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease Wit…

News

INSM ▲ +0.4% - Insmed Incorporated

CP $120.50▲ +0.4%Sep 16, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Expands Community Impact During Fifth Annual Global Day of Good…

News

INSM ▼ -1.1% - Insmed Incorporated

CP $125.31▲ -1.1%Sep 4, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)…

News

INSM ▲ +0.2% - Insmed Incorporated

CP $126.90▲ +0.2%Sep 3, 2026 · ThinkSabio Blog

$INSM INSM - Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension)…

SEC 13D/G

INSM - Insmed Incorporated - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$130.90▼ -26.09%Aug 6, 2026 · ThinkSabio Blog

$INSM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #INSM Insmed Incorporated : $130.90 Sector: Healthcare | YTD: 🔽…

SEC 13D/G

$INSM SEC Filing Update (22-JUL-2026) | ThinkSabio - Stocks Simplified

$106.79▼ -39.70%Jul 22, 2026 · ThinkSabio Blog

$INSM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #INSM : $106.79 Sector: Healthcare | YTD: 🔽 -39.70% The SEC disc…